VASCONEQNSEVascon Engineers Limited· ConstructionHighNeutral
Announced Mon, 4 Aug, 2025 · 14:54 IST

Outcome of the Board Meeting held on August 04, 2025

Pat Growth 25pctEmphasis Of MatterResults View source PDFExplain this filing

VASCONEQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+3.9%Reaction day
₹53.38
prior close
₹55.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+3.4% vs market

On the reaction day the stock moved 3.4 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.6
10m
+1.6
15m
+1.0
30m
+0.7
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+3.9+0.5+3.4
Next day
-1.0+0.2-1.2
2d
-5.8-0.9-4.9
3d
-5.8-1.2-4.5
4d
-7.8-2.0-5.8
5d
-7.2-1.9-5.4
1w
-8.2-1.2-7.0
15d
-6.6-1.5-5.1
1m
-0.3+0.0-0.4
2m
+27.4-0.5+27.8
3m
+28.1+1.3+26.9
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vascon Engineers' board approved its Q1 FY26 (quarter ended June 30, 2025) standalone and consolidated unaudited results. Standalone revenue from operations rose to Rs. 22,091 lakhs from Rs. 19,583 lakhs a year ago (up ~13%), while standalone profit after tax surged to Rs. 2,193 lakhs from Rs. 866 lakhs (up ~153%). Consolidated PAT stood at Rs. 2,247 lakhs versus Rs. 960 lakhs. The big jump in PAT was largely fuelled by a one-time Rs. 17.50 crore gain from the sale of its investment in Ascent Hotels. The auditor, Sharp & Tannan Associates, issued an unmodified (clean) limited review report but flagged an Emphasis of Matter about the disputed divestment of its subsidiary Almet Corporation Limited. The board also approved the reappointment of Dr. Santosh Sundararajan as Whole Time Director and Group CEO for five years from May 31, 2026 and revised the remuneration of Managing Director Mr. Siddharth Vasudevan Moorthy for three years from April 1, 2025, both subject to shareholder approval. The AGM is set for September 24, 2025.

Likely market impact

Q1 results are strong on the surface, but most of the profit jump comes from a one-time investment sale rather than core operations, so underlying earnings growth is more modest. The Almet Corporation dispute is a pending watch item. Shareholders will need to approve the director reappointment and revised MD remuneration at the upcoming AGM.